EUCTR2011-001033-16-DK进行中（未招募）1 期
Safety and Efficacy of turoctocog alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients with Haemophilia A - guardian™4
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Informed consent obtained before any trial-related activities (trial-related activities are any procedure that would not have been performed during normal management of the patient)
- •- Male patients diagnosed with congenital severe haemophilia A (FVIII = 1%)
- •- Age < 6 years
- •- No prior use of purified clotting FVIII products (previous exposure, equal to or less than 5 ED to blood components, e.g. cryoprecipitate, fresh frozen plasma is accepted) including commercially available NovoEight® /Novoeight®
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 60
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Known or suspected allergy to hamster protein or intolerance to trial product(s) or related products
- •- Previous participation in this trial defined as withdrawal after administration of trial product
- •- Congenital or acquired coagulation disorders other than haemophilia A
- •- Any history of FVIII inhibitor
- •- Ongoing treatment or planned treatment during the trial with immunomodulatory agents (e.g. intravenous immunoglobulin (IVIG)), routine systemic corticosteroids)
研究者
相似试验
进行中（未招募）
1 期
Safety and efficacy of turoctocog alfa inprevention and treatment of bleeds in paediatricpreviously untreated patients with Haemophilia AEUCTR2011-001033-16-ATovo Nordisk A/S60
进行中（未招募）
1 期
Safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 18.0Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 100000004850EUCTR2011-001033-16-LTovo Nordisk A/S60
进行中（未招募）
1 期
Safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 18.0 Level: LLT Classification code 10018937 Term: Haemophilia A System Organ Class: 100000004850EUCTR2011-001033-16-PTovo Nordisk A/S60
进行中（未招募）
1 期
Safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 100000004850EUCTR2011-001033-16-PLovo Nordisk A/S60
进行中（未招募）
1 期
Safety and Efficacy of turoctocog alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients with Haemophilia A - guardian™4Haemophilia AMedDRA version: 17.1Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 100000004850EUCTR2011-001033-16-HUovo Nordisk A/S60